Assessment of Adverse Events Following COVID-19 Vaccination: A Cross-sectional Study in Ibadan, Nigeria
View abstract on PubMed
Summary
This summary is machine-generated.Most recipients of the AstraZeneca/Oxford COVID-19 vaccine in Ibadan experienced mild adverse events following immunization (AEFI). Previous COVID-19 infection increased the risk of AEFI, but most reactions were self-limiting.
Area Of Science
- Immunology
- Public Health
- Epidemiology
Background
- COVID-19 vaccination is crucial for pandemic control and saving lives.
- The AstraZeneca/Oxford vaccine is a key tool in global immunization efforts.
- Understanding vaccine safety, including adverse events, is vital for public trust and vaccine uptake.
Purpose Of The Study
- To evaluate the spectrum of adverse events following immunization (AEFI) with the COVID-19 AstraZeneca/Oxford vaccine.
- To identify the frequency and types of AEFI in Ibadan, Nigeria.
- To explore factors associated with AEFI, such as previous COVID-19 infection.
Main Methods
- A cross-sectional study involving 369 adults vaccinated with AstraZeneca/Oxford COVID-19 vaccine in Ibadan, Nigeria.
- Data collected via structured questionnaires on adverse events following immunization.
- Analysis of AEFI frequency, types, timing, and associated risk factors.
Main Results
- 90% of participants reported at least one AEFI.
- Most frequent AEFI included headache (21.1%), fatigue (17.4%), and injection site pain (9.3%).
- 96.4% of AEFI occurred within 48 hours; severe AEFI occurred in 1.2%. Previous COVID-19 infection increased AEFI odds (OR 7.0).
Conclusions
- The study found a high frequency of AEFI with the AstraZeneca/Oxford vaccine in Ibadan.
- The majority of reported AEFI were mild and self-limiting.
- Previous COVID-19 infection is a significant risk factor for experiencing AEFI.
Related Concept Videos
Overview
Vaccination is the administration of antigenic material from pathogens to confer immunity against a specific microorganism. Vaccination primes the immune system to recognize and mount an immune response faster and more effectively if the real pathogen is encountered. Vaccinations are one of the most efficient ways to protect both individual humans and the general public from disease. A growing anti-vaccination skepticism risks the successes of vaccination programs that helped reduce...
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...

